SCHEMBL7968884

SCHEMBL7968884

CCCC(=O)Cc1ccc(NC(=O)OC(C)(C)C)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.41
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ PIK3CD O00329 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ PI4KB Q9UBF8 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6587449 0.85 GAA (0.54) HTTMTNR1AMTNR1BSMN1; SMN2GAA
SCHEMBL12044500 0.85 HTT (0.47) HTTMTNR1AMTNR1BSMN1; SMN2GAA
SCHEMBL20080089 0.83 PPARG (0.48) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL15752675 0.82 PYGL (0.48) HTTMTNR1AMTNR1BNPC1RAB9A
SCHEMBL29180821 0.82 MTNR1A (0.42) HTTMTNR1AMTNR1BSMN1; SMN2GAA
SCHEMBL2156903 0.79 MTNR1B (0.40) MTNR1BGAAKMT2AALDH1A1
SCHEMBL7962276 0.79 AKR1C3 (0.41) MTNR1AMTNR1BSMN1; SMN2NPC1RAB9A
SCHEMBL19966996 0.78 MAPT (0.44) HTTMTNR1AMTNR1BGAAPIK3CD
SCHEMBL19930248 0.77 MAPT (0.43) HTTMTNR1AMTNR1BGAAPIK3CD
SCHEMBL8291777 0.77 KCNQ4 (0.43) SMN1; SMN2PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 — — US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 — — EP disclosed
EP-0620214-B1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors LILLY CO ELI (US) 1999-03-03 — — EP disclosed
US-5684034-A INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE ELI LILLY AND COMPANY (US) 1997-11-04 — — US disclosed
US-5578634-A SEPTIC SHOCK TREATMENT ELI LILLY AND COMPANY (US) 1996-11-26 — — US disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 — — EP disclosed
EP-0620214-A1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 — — EP disclosed
Send feedback